{"observationCode":"166","observationTitle":"Travel to countries with high or intermediate prevalence of chronic HBV infection","group":"","indicationText":"Administered to persons who travel to countries with high or intermediate prevalence of chronic HBV infection.","contraindicationText":"","clarifyingText":"","codedValues":[]}